The management and prevention of premalignant penile lesions

Scandinavian Journal of Urology and Nephrology, Supplement

Volumn 34, Issue 205, 2000, Pages 220-229

  Von Krogh, Geo ^a   Horenblas, Simon ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IMIQUIMOD; PODOPHYLLOTOXIN;

BOWEN DISEASE; BOWENOID PAPULOSIS; CANCER PREVENTION; CANCER SCREENING; CONDYLOMA; CONFERENCE PAPER; CRYOSURGERY; DIAGNOSTIC APPROACH ROUTE; ERYTHROPLASIA; HEALTH CARE POLICY; HISTOPATHOLOGY; HUMAN; PENIS CANCER; PHIMOSIS; PRACTICE GUIDELINE; PRECANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UNITED KINGDOM; ADJUVANT CHEMOTHERAPY; ARTICLE; CARCINOMA IN SITU; EVIDENCE BASED MEDICINE; MALE; MULTIMODALITY CANCER THERAPY; PENIS TUMOR;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; MALE; PENILE NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 0034353143     PISSN: 03008886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Jensen MS. Cancer of the penis in Denmark 1942 to 1962 (511 cases). Dan Med Bull 1977; 24: 66-72.
2. Young MJ, Reda DJ, Waters WB. Penile carcinoma: a twenty-five-year experience. Urology 1991; 38: 529-32.
3. Taylor CA, Keller ML, Egan JJ. Advice from affected persons about living with human papillomavirus infection. Image J Nurs Sch 1997; 29: 27-32.
4. Maw RD, Reitano M, Roy M. An international survey of patients with genital warts; perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998; 9: 571-8.
5. Gross GE, Tyring SK, von Krogh G, Barrasso R. External genitalia: treatment. In: Gross GE, Barrasso R, eds. Human papillomavirus infection. Berlin/Wiesbaden: Ullstein Mosby, 1997: 365-76.
6. Ferenzcy A, von Krogh G. External genital warts: current and new therapies. J Genital Infect Neoplasia 2000: 17-27.
7. Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998; 47(RR-1): 1-111.
8. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). UK National guideline for the management of anogenital warts. Sex Transm Infect 1999; 75 Suppl 1: S71-5.
9. Cowen FM. Evidence-based medicine: an overview. Int J STD AIDS 1999; 10: 5-7.
10. Gross G, von Krogh G, Barrasso R. Genitoanal lesions. In: Gross G, von Krogh G, eds. Human papillomavirus infections in dermatovenereology. Boca Raton, FL: CRC Press, 1997: 389-416.
11. Von Krogh G, Lacey CJN, Gross G, Barrasso R, Schneider A. European Course of HPV-associated pathology: Guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect 2000: in press.
12. Von Krogh G. Podophyllotoxin in serum: absorption subsequent to three-day repeated application of a 0.5% ethanol preparation on condylomata acuminata. Sex Transm Dis 1982; 9: 26-30.
13. Edwards L, Ferenczy A, Eron L, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998; 134: 25-30.